Nara P[au] - Search Results

Year	Number of Results
1976	1
1979	1
1982	1
1983	2
1987	9
1988	4
1989	9
1990	9
1991	11
1992	12
1993	7
1994	7
1995	4
1996	6
1997	6
1998	5
1999	5
2000	1
2001	1
2005	1
2007	2
2008	2
2010	7
2011	3
2013	1
2014	2
2019	2
2020	3
2021	2
2022	3
2023	0

1

Transcriptomic analysis of human sensory neurons in painful diabetic neuropathy reveals inflammation and neuronal loss.

Hall BE, Macdonald E, Cassidy M, Yun S, Sapio MR, Ray P, Doty M, Nara P, Burton MD, Shiers S, Ray-Chaudhury A, Mannes AJ, Price TJ, Iadarola MJ, Kulkarni AB. Hall BE, et al. Among authors: nara p. Sci Rep. 2022 Mar 18;12(1):4729. doi: 10.1038/s41598-022-08100-8. Sci Rep. 2022. PMID: 35304484 Free PMC article.

2

Expert Panel Discussion on Antigenic Sin.

Kieber-Emmons T, Brown E, Nara P, Kohler H. Kieber-Emmons T, et al. Among authors: nara p. Monoclon Antib Immunodiagn Immunother. 2021 Oct;40(5):203-209. doi: 10.1089/mab.2021.0047. Monoclon Antib Immunodiagn Immunother. 2021. PMID: 34678097 No abstract available.

3

Brucellosis as a Transboudary Infection of Animals and Humans which Needs to be Managed by Cooperative Efforts of Different Countries. Introduction.

Wolfram JH, Nara PL. Wolfram JH, et al. Among authors: nara pl. Vaccine. 2010 Oct 1;28 Suppl 5:F1-2. doi: 10.1016/j.vaccine.2010.04.022. Vaccine. 2010. PMID: 20850687 No abstract available.

4

Antibody neutralization of retargeted measles viruses.

Lech PJ, Pappoe R, Nakamura T, Tobin GJ, Nara PL, Russell SJ. Lech PJ, et al. Among authors: nara pl. Virology. 2014 Apr;454-455:237-46. doi: 10.1016/j.virol.2014.01.027. Epub 2014 Mar 14. Virology. 2014. PMID: 24725950 Free PMC article.

5

Deceptive imprinting: a cosmopolitan strategy for complicating vaccination.

Nara PL, Garrity R. Nara PL, et al. Vaccine. 1998 Nov;16(19):1780-7. doi: 10.1016/s0264-410x(98)00168-6. Vaccine. 1998. PMID: 9795381 Review. No abstract available.

6

Neutralization of HIV-1: a paradox of humoral proportions.

Nara PL, Garrity RR, Goudsmit J. Nara PL, et al. FASEB J. 1991 Jul;5(10):2437-55. doi: 10.1096/fasebj.5.10.1712328. FASEB J. 1991. PMID: 1712328 Review.

7

Designing immunogens to elicit broadly neutralizing antibodies to the HIV-1 envelope glycoprotein.

Lin G, Nara PL. Lin G, et al. Among authors: nara pl. Curr HIV Res. 2007 Nov;5(6):514-41. doi: 10.2174/157016207782418489. Curr HIV Res. 2007. PMID: 18045109 Review.

8

Deceptive imprinting: insights into mechanisms of immune evasion and vaccine development.

Nara PL. Nara PL. Adv Vet Med. 1999;41:115-34. doi: 10.1016/s0065-3519(99)80012-3. Adv Vet Med. 1999. PMID: 9890013 Review. No abstract available.

9

Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development.

Goudsmit J, Back NK, Nara PL. Goudsmit J, et al. Among authors: nara pl. FASEB J. 1991 Jul;5(10):2427-36. doi: 10.1096/fasebj.5.10.2065891. FASEB J. 1991. PMID: 2065891 Review.

10

Early antibody responses map to non-protective, PCV2 capsid protein epitopes.

Ilha M, Nara P, Ramamoorthy S. Ilha M, et al. Among authors: nara p. Virology. 2020 Jan 15;540:23-29. doi: 10.1016/j.virol.2019.11.008. Epub 2019 Nov 8. Virology. 2020. PMID: 31734380 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results